{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:02:15Z","timestamp":1791943335153,"version":"4.3.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01478"],"award-info":[{"award-number":["PI19\/01478"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["P20_00346"],"award-info":[{"award-number":["P20_00346"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s13346-024-01701-y","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T12:02:25Z","timestamp":1725537745000},"page":"1646-1659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Magnetic and pH-responsive magnetite\/chitosan (core\/shell) nanoparticles for dual-targeted methotrexate delivery in cancer therapy"],"prefix":"10.1007","volume":"15","author":[{"given":"Ana","family":"Medina-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen M.","family":"El-Hammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema I.","family":"Mart\u00ednez-Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier G.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracia","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-3791","authenticated-orcid":false,"given":"Jos\u00e9 L.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"1701_CR1","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.3390\/ijms21103483","volume":"21","author":"P Kozminski","year":"2020","unstructured":"Kozminski P, Halik PK, Chesori R, Gniazdowska E. Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers. Int J Mol Sci. 2020;21:3483. https:\/\/doi.org\/10.3390\/ijms21103483.","journal-title":"Int J Mol Sci"},{"key":"1701_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020;16:145\u201354. https:\/\/doi.org\/10.1038\/s41584-020-0373-9.","journal-title":"Nat Rev Rheumatol"},{"key":"1701_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00280-012-2062-0","volume":"71","author":"SS Abolmaali","year":"2013","unstructured":"Abolmaali SS, Tamaddon AM, Dinarvand R. A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis. Cancer Chemother Pharmacol. 2013;71:1115\u201330. https:\/\/doi.org\/10.1007\/s00280-012-2062-0.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1701_CR4","doi-asserted-by":"publisher","first-page":"104969","DOI":"10.1016\/j.jddst.2023.104969","volume":"88","author":"S Kumar","year":"2023","unstructured":"Kumar S, Garg NK, Jain A, Khopade A, Pandey P, Sawant KK. Nanocarriers mediated delivery of methotrexate is instrumental in treating auto-immune diseases and cancer. J Drug Deliv Sci Technol. 2023;88:104969. https:\/\/doi.org\/10.1016\/j.jddst.2023.104969.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1701_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7326\/M19-3369","volume":"172","author":"DH Solomon","year":"2020","unstructured":"Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N, Dellaripa PF, Everett BM, Pradhan AD, Hammond SP, Murray M, Rao DA, Ritter SY, Rutherford A, Sparks JA, Stratton J, Suh DH, Tedeschi SK, Vanni KMM, Paynter NP, Ridker PM. Adverse effects of low-dose methotrexate: a randomized trial. Ann Intern Med. 2020;172:369\u201380. https:\/\/doi.org\/10.7326\/M19-3369.","journal-title":"Ann Intern Med"},{"key":"1701_CR6","doi-asserted-by":"publisher","first-page":"1200670","DOI":"10.3389\/fbiom.2023.1200670","volume":"2","author":"M Mukhtar","year":"2023","unstructured":"Mukhtar M, Ezra Manicum AL, Shojaei Barjouei M, Eshaghi Malekshah R, Behzadmehr R, Rahdar A, Ghotekar S, Baino F. Nanocarriers for methotrexate delivery\/codelivery in the frame of cancer diagnostics and treatment: a review. Front Biomater Sci. 2023;2:1200670. https:\/\/doi.org\/10.3389\/fbiom.2023.1200670.","journal-title":"Front Biomater Sci"},{"key":"1701_CR7","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/pharmaceutics14102073","volume":"14","author":"BR Giri","year":"2022","unstructured":"Giri BR, Yang HS, Song IS, Choi HG, Cho JH, Kim DW. Alternative methotrexate oral formulation: enhanced aqueous solubility, bioavailability, photostability, and permeability. Pharmaceutics. 2022;14:2073. https:\/\/doi.org\/10.3390\/pharmaceutics14102073.","journal-title":"Pharmaceutics"},{"key":"1701_CR8","doi-asserted-by":"publisher","first-page":"39482","DOI":"10.1039\/C5RA03546E","volume":"5","author":"S Ray","year":"2015","unstructured":"Ray S, Joy M, Sa B, Ghosh S, Chakraborty J. pH dependent chemical stability and release of methotrexate from a novel nanoceramic carrier. RSC Adv. 2015;5:39482\u201394. https:\/\/doi.org\/10.1039\/C5RA03546E.","journal-title":"RSC Adv"},{"key":"1701_CR9","doi-asserted-by":"publisher","first-page":"11049","DOI":"10.1007\/s11033-022-07782-7","volume":"49","author":"H Shariatifar","year":"2022","unstructured":"Shariatifar H, Ranjbarian F, Hajiahmadi F, Farasat A. A comprehensive review on methotrexate containing nanoparticles; an appropriate tool for cancer treatment. Mol Biol Rep. 2022;49:11049\u201360. https:\/\/doi.org\/10.1007\/s11033-022-07782-7.","journal-title":"Mol Biol Rep"},{"key":"1701_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","volume":"16","author":"S Gavas","year":"2021","unstructured":"Gavas S, Quazi S, Karpinski TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett. 2021;16:173. https:\/\/doi.org\/10.1186\/s11671-021-03628-6.","journal-title":"Nanoscale Res Lett"},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1039\/d2ra07863e","volume":"13","author":"MJ Nirmala","year":"2023","unstructured":"Nirmala MJ, Kizhuveetil U, Johnson A, Balaji G, Nagarajan R, Muthuvijayan V. Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv. 2023;13:8606\u201329. https:\/\/doi.org\/10.1039\/d2ra07863e.","journal-title":"RSC Adv"},{"key":"1701_CR12","first-page":"1009","volume-title":"Handbook of nanoparticles","author":"MM El-Hammadi","year":"2015","unstructured":"El-Hammadi MM, Arias JL. Advanced engineering approaches in the development of PLGA-based nanomedicines. In: Aliofkhazraei M, editor. Handbook of nanoparticles. Cham: Springer International Publishing AG; 2015. pp. 1009\u201339."},{"key":"1701_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S, Tong R, Miao YB, Cai L. Smart nanoparticles for cancer therapy. Signal Transduct Target Ther. 2023;8:418. https:\/\/doi.org\/10.1038\/s41392-023-01642-x.","journal-title":"Signal Transduct Target Ther"},{"key":"1701_CR14","doi-asserted-by":"publisher","first-page":"39736","DOI":"10.1021\/acsami.2c06627","volume":"14","author":"R Rebollo","year":"2022","unstructured":"Rebollo R, Oyoun F, Corvis Y, El-Hammadi MM, Saubamea B, Andrieux K, Mignet N, Alhareth K. Microfluidic manufacturing of liposomes: development and optimization by design of experiment and machine learning. ACS Appl Mater Interfaces. 2022;14:39736\u201345. https:\/\/doi.org\/10.1021\/acsami.2c06627.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1701_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.phrs.2019.01.013","volume":"141","author":"J Jim\u00e9nez-L\u00f3pez","year":"2019","unstructured":"Jim\u00e9nez-L\u00f3pez J, El-Hammadi MM, Ortiz R, Cayero-Otero MD, Cabeza L, Perazzoli G, Martin-Banderas L, Baeyens JM, Prados J, Melguizo C. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer. Pharmacol Res. 2019;141:451\u201365. https:\/\/doi.org\/10.1016\/j.phrs.2019.01.013.","journal-title":"Pharmacol Res"},{"key":"1701_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2016.11.012","volume":"516","author":"MM El-Hammadi","year":"2017","unstructured":"El-Hammadi MM, Delgado \u00c1V, Melguizo C, Prados JC, Arias JL. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. Int J Pharm. 2017;516:61\u201370. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.012.","journal-title":"Int J Pharm"},{"key":"1701_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.34172\/bi.2022.23433","volume":"12","author":"L Cabeza","year":"2022","unstructured":"Cabeza L, El-Hammadi MM, Ortiz R, Cayero-Otero MD, Jim\u00e9nez-L\u00f3pez J, Perazzoli G, Martin-Banderas L, Baeyens JM, Melguizo C, Prados J. Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer. BioImpacts. 2022;12:515\u201331. https:\/\/doi.org\/10.34172\/bi.2022.23433.","journal-title":"BioImpacts"},{"key":"1701_CR18","doi-asserted-by":"publisher","first-page":"113345","DOI":"10.1016\/j.indcrop.2021.113345","volume":"164","author":"MM El-Hammadi","year":"2021","unstructured":"El-Hammadi MM, Small-Howard AL, Fern\u00e1ndez-Ar\u00e9valo M, Mart\u00edn-Banderas L. Development of enhanced drug delivery vehicles for three cannabis-based terpenes using poly(lactic-co-glycolic acid) based nanoparticles. Ind Crop Prod. 2021;164:113345. https:\/\/doi.org\/10.1016\/j.indcrop.2021.113345.","journal-title":"Ind Crop Prod"},{"key":"1701_CR19","doi-asserted-by":"publisher","first-page":"121524","DOI":"10.1016\/j.ijpharm.2022.121524","volume":"616","author":"MM El-Hammadi","year":"2022","unstructured":"El-Hammadi MM, Small-Howard AL, Jansen C, Fernandez-Arevalo M, Turner H, Martin-Banderas L. Potential use for chronic pain: poly(ethylene glycol)-poly(lactic-co-glycolic acid) nanoparticles enhance the effects of cannabis-based terpenes on calcium influx in TRPV1-expressing cells. Int J Pharm. 2022;616:121524. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121524.","journal-title":"Int J Pharm"},{"key":"1701_CR20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/B978-0-08-102985-5.00026-7","volume-title":"Nanoengineered Biomaterials for Advanced Drug Delivery","author":"MM El-Hammadi","year":"2020","unstructured":"El-Hammadi MM, Arias JL. Nanotechnology for vaginal drug delivery and targeting. In: Mozafari M, editor. Nanoengineered Biomaterials for Advanced Drug Delivery. Amsterdam: Elsevier Ltd.; 2020. pp. 647\u201382."},{"key":"1701_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41568-022-00496-9","volume":"22","author":"SN Bhatia","year":"2022","unstructured":"Bhatia SN, Chen X, Dobrovolskaia MA, Lammers T. Cancer nanomedicine. Nat Rev Cancer. 2022;22:550\u20136. https:\/\/doi.org\/10.1038\/s41568-022-00496-9.","journal-title":"Nat Rev Cancer"},{"key":"1701_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-12-820466-5.00011-9","volume-title":"Theory and applications of Nonparenteral Nanomedicines","author":"MM El-Hammadi","year":"2021","unstructured":"El-Hammadi MM, Arias JL. Nanomedicine for vaginal drug delivery. In: Kesharwani P, Taurin S, Greish K, editors. Theory and applications of Nonparenteral Nanomedicines. London: Academic; 2021. pp. 235\u201357."},{"key":"1701_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/nano12030354","volume":"12","author":"MM El-Hammadi","year":"2022","unstructured":"El-Hammadi MM, Arias JL. Recent advances in the surface functionalization of PLGA-based nanomedicines. Nanomaterials (Basel). 2022;12:354. https:\/\/doi.org\/10.3390\/nano12030354.","journal-title":"Nanomaterials (Basel)"},{"key":"1701_CR24","doi-asserted-by":"publisher","first-page":"1700289","DOI":"10.1002\/advs.201700289","volume":"5","author":"L Fan","year":"2017","unstructured":"Fan L, Zhang S, Zhang C, Yin C, Chu Z, Song C, Lin G, Li Q. Multidrug resistance in cancer circumvented using a cytosolic drug reservoir. Adv Sci (Weinh). 2017;5:1700289. https:\/\/doi.org\/10.1002\/advs.201700289.","journal-title":"Adv Sci (Weinh)"},{"key":"1701_CR25","doi-asserted-by":"publisher","first-page":"117943","DOI":"10.1016\/j.lfs.2020.117943","volume":"256","author":"F Madani","year":"2020","unstructured":"Madani F, Esnaashari SS, Bergonzi MC, Webster TJ, Younes HM, Khosravani M, Adabi M. Paclitaxel\/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: formulation development and in vitro antitumor activity evaluation. Life Sci. 2020;256:117943. https:\/\/doi.org\/10.1016\/j.lfs.2020.117943.","journal-title":"Life Sci"},{"key":"1701_CR26","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.3390\/ijms20133312","volume":"20","author":"JH Jang","year":"2019","unstructured":"Jang JH, Jeong SH, Lee YB. Preparation and in vitro\/in vivo characterization of polymeric nanoparticles containing methotrexate to improve lymphatic delivery. Int J Mol Sci. 2019;20:3312. https:\/\/doi.org\/10.3390\/ijms20133312.","journal-title":"Int J Mol Sci"},{"key":"1701_CR27","doi-asserted-by":"publisher","first-page":"110515","DOI":"10.1016\/j.colsurfb.2019.110515","volume":"184","author":"MA Vakilinezhad","year":"2019","unstructured":"Vakilinezhad MA, Amini A, Dara T, Alipour S. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: in vitro and in vivo evaluation. Colloids Surf B Biointerfaces. 2019;184:110515. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110515.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1701_CR28","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.3390\/ijms23052725","volume":"23","author":"S Noreen","year":"2022","unstructured":"Noreen S, Hasan S, Ghumman SA, Bukhari SNA, Ijaz B, Hameed H, Iqbal H, Aslam A, Elsherif MAM, Noureen S, Ejaz H. pH responsive Abelmoschus esculentus mucilage and administration of methotrexate: in-vitro antitumor and in-vivo toxicity evaluation. Int J Mol Sci. 2022;23:2725. https:\/\/doi.org\/10.3390\/ijms23052725.","journal-title":"Int J Mol Sci"},{"key":"1701_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2018.12.014","volume":"124","author":"AI Barbosa","year":"2019","unstructured":"Barbosa AI, Costa Lima SA, Reis S. Development of methotrexate loaded fucoidan\/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation. Int J Biol Macromol. 2019;124:1115\u201322. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.12.014.","journal-title":"Int J Biol Macromol"},{"key":"1701_CR30","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/pi.5890","volume":"68","author":"M Saraei","year":"2019","unstructured":"Saraei M, Sarvari R, Massoumi B, Agbolaghi S. Co-delivery of methotrexate and doxorubicin via nanocarriers of star-like poly(DMAEMA-block-HEMA-block-AAc) terpolymers. Polym Int. 2019;68:1795\u2013803. https:\/\/doi.org\/10.1002\/pi.5890.","journal-title":"Polym Int"},{"key":"1701_CR31","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.3390\/ma15196521","volume":"15","author":"SM Bashir","year":"2022","unstructured":"Bashir SM, Ahmed Rather G, Patr\u00edcio A, Haq Z, Sheikh AA, Shah MZUH, Singh H, Khan AA, Imtiyaz S, Ahmad SB, Nabi S, Rakhshan R, Hassan S, Fonte P. Chitosan nanoparticles: a versatile platform for biomedical applications. Mater (Basel). 2022;15:6521. https:\/\/doi.org\/10.3390\/ma15196521.","journal-title":"Mater (Basel)"},{"key":"1701_CR32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/pharmaceutics15041313","volume":"15","author":"N Desai","year":"2023","unstructured":"Desai N, Rana D, Salave S, Gupta R, Patel P, Karunakaran B, Sharma A, Giri J, Benival D, Kommineni N. Chitosan: a potential biopolymer in drug delivery and biomedical applications. Pharmaceutics. 2023;15:1313. https:\/\/doi.org\/10.3390\/pharmaceutics15041313.","journal-title":"Pharmaceutics"},{"key":"1701_CR33","doi-asserted-by":"publisher","first-page":"105634","DOI":"10.1016\/j.reactfunctpolym.2023.105634","volume":"191","author":"A Harugade","year":"2023","unstructured":"Harugade A, Sherje AP, Pethe A. Chitosan: a review on properties, biological activities and recent progress in biomedical applications. React Funct Polym. 2023;191:105634. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2023.105634.","journal-title":"React Funct Polym"},{"key":"1701_CR34","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.3390\/polym14163410","volume":"14","author":"LE Puluhulawa","year":"2022","unstructured":"Puluhulawa LE, Joni IM, Elamin KM, Mohammed AFA, Muchtaridi M, Wathoni N. Chitosan-hyaluronic acid nanoparticles for active targeting in cancer therapy. Polym (Basel). 2022;14:3410. https:\/\/doi.org\/10.3390\/polym14163410.","journal-title":"Polym (Basel)"},{"key":"1701_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijbiomac.2021.12.070","volume":"199","author":"D Geethakumari","year":"2022","unstructured":"Geethakumari D, Bhaskaran Sathyabhama A, Raji Sathyan K, Mohandas D, Somasekharan JV, Thavarool Puthiyedathu S. Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines. Int J Biol Macromol. 2022;199:150\u201361. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.12.070.","journal-title":"Int J Biol Macromol"},{"key":"1701_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12935-021-02025-4","volume":"21","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, Rapposelli S, Akram M, Iqbal M, Krishna A, Kumar NVA, Braga SS, Cardoso SM, Jafernik K, Ekiert H, Cruz-Martins N, Szopa A, Villagran M, Mardones L, Martorell M, Docea AO, Calina D. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer Cell Int. 2021;21:318. https:\/\/doi.org\/10.1186\/s12935-021-02025-4.","journal-title":"Cancer Cell Int"},{"key":"1701_CR37","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/pharmaceutics13081232","volume":"13","author":"F Fern\u00e1ndez-\u00c1lvarez","year":"2021","unstructured":"Fern\u00e1ndez-\u00c1lvarez F, Garc\u00eda-Garc\u00eda G, Arias JL. A tri-stimuli responsive (maghemite\/PLGA)\/chitosan nanostructure with promising applications in lung cancer. Pharmaceutics. 2021;13:1232. https:\/\/doi.org\/10.3390\/pharmaceutics13081232.","journal-title":"Pharmaceutics"},{"key":"1701_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","volume":"9","author":"MA Mohammed","year":"2017","unstructured":"Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017;9:53. https:\/\/doi.org\/10.3390\/pharmaceutics9040053.","journal-title":"Pharmaceutics"},{"key":"1701_CR39","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","volume":"13","author":"N Aibani","year":"2021","unstructured":"Aibani N, Rai R, Patel P, Cuddihy G, Wasan EK. Chitosan nanoparticles at the biological interface: implications for drug delivery. Pharmaceutics. 2021;13:1686. https:\/\/doi.org\/10.3390\/pharmaceutics13101686.","journal-title":"Pharmaceutics"},{"key":"1701_CR40","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1039\/D1TB00354B","volume":"9","author":"F Fern\u00e1ndez-\u00c1lvarez","year":"2021","unstructured":"Fern\u00e1ndez-\u00c1lvarez F, Caro C, Garc\u00eda-Garc\u00eda G, Garc\u00eda-Mart\u00edn ML, Arias JL. Engineering of stealth (maghemite\/PLGA)\/chitosan (core\/shell)\/shell nanocomposites with potential applications for combined MRI and hyperthermia against cancer. J Mater Chem B. 2021;9:4963\u201380. https:\/\/doi.org\/10.1039\/D1TB00354B.","journal-title":"J Mater Chem B"},{"key":"1701_CR41","doi-asserted-by":"publisher","first-page":"104594","DOI":"10.1016\/j.jddst.2023.104594","volume":"86","author":"A Medina-Moreno","year":"2023","unstructured":"Medina-Moreno A, El-Hammadi MM, Arias JL. pH-dependent, extended release and enhanced in vitro efficiency against colon cancer of Tegafur formulated using chitosan-coated poly(\u03b5-caprolactone) nanoparticles. J Drug Deliv Sci Technol. 2023;86:104594. https:\/\/doi.org\/10.1016\/j.jddst.2023.104594.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1701_CR42","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/mp2005615","volume":"9","author":"Z Amoozgar","year":"2012","unstructured":"Amoozgar Z, Park J, Lin Q, Yeo Y. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Mol Pharm. 2012;9:1262. https:\/\/doi.org\/10.1021\/mp2005615.","journal-title":"Mol Pharm"},{"key":"1701_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.carbpol.2013.01.072","volume":"94","author":"RA Ishak","year":"2013","unstructured":"Ishak RA, Awad GA, Zaki NM, El-Shamy Ael H, Mortada ND. A comparative study of chitosan shielding effect on nano-carriers hydrophilicity and biodistribution. Carbohydr Polym. 2013;94:669\u201376. https:\/\/doi.org\/10.1016\/j.carbpol.2013.01.072.","journal-title":"Carbohydr Polym"},{"key":"1701_CR44","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1039\/d3na00253e","volume":"5","author":"T Baati","year":"2023","unstructured":"Baati T, Chaabani I, Salek A, Njim L, Selmi M, Al-Kattan A, Hosni K. Chitosan-coated ultrapure silicon nanoparticles produced by laser ablation: biomedical potential in nano-oncology as a tumor-targeting nanosystem. Nanoscale Adv. 2023;5:3044\u201352. https:\/\/doi.org\/10.1039\/d3na00253e.","journal-title":"Nanoscale Adv"},{"key":"1701_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","volume":"351","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release. 2022;351:923\u201340. https:\/\/doi.org\/10.1016\/j.jconrel.2022.10.005.","journal-title":"J Control Release"},{"key":"1701_CR46","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2174\/1871520616666160101120040","volume":"16","author":"SG Nur","year":"2016","unstructured":"Nur SG, Buket O, Sezgi K, Cagdas A, Cansu A, Guliz A, Habibe Y, Cigir BA, Yavuz D, Senay HS. Synthesis of methotrexate loaded chitosan nanoparticles and in vitro evaluation of the potential in treatment of prostate cancer. Anticancer Agents Med Chem. 2016;16:1038\u201342. https:\/\/doi.org\/10.2174\/1871520616666160101120040.","journal-title":"Anticancer Agents Med Chem"},{"key":"1701_CR47","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1016\/j.biomaterials.2013.01.005","volume":"34","author":"DR Nogueira","year":"2013","unstructured":"Nogueira DR, Tavano L, Mitjans M, Perez L, Infante MR, Vinardell MP. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. Biomaterials. 2013;34:2758\u201372. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.005.","journal-title":"Biomaterials"},{"key":"1701_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/pharmaceutics12010026","volume":"12","author":"E Mazzotta","year":"2019","unstructured":"Mazzotta E, De Benedittis S, Qualtieri A, Muzzalupo R. Actively targeted and redox responsive delivery of anticancer drug by chitosan nanoparticles. Pharmaceutics. 2019;12:26. https:\/\/doi.org\/10.3390\/pharmaceutics12010026.","journal-title":"Pharmaceutics"},{"key":"1701_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/ph15020149","volume":"15","author":"N Al-Nemrawi","year":"2022","unstructured":"Al-Nemrawi N, Hameedat F, Al-Husein B, Nimrawi S. Photolytic controlled release formulation of methotrexate loaded in chitosan\/TiO(2) nanoparticles for breast cancer. Pharmaceuticals (Basel). 2022;15:149. https:\/\/doi.org\/10.3390\/ph15020149.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1701_CR50","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1021\/cr300068p","volume":"112","author":"LH Reddy","year":"2012","unstructured":"Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112:5818\u201378. https:\/\/doi.org\/10.1021\/cr300068p.","journal-title":"Chem Rev"},{"key":"1701_CR51","doi-asserted-by":"publisher","first-page":"100163","DOI":"10.1016\/j.apsadv.2021.100163","volume":"6","author":"CM Mater\u00f3n Em, Miyazaki","year":"2021","unstructured":"Mater\u00f3n Em, Miyazaki CM, Carr O, Joshi N, Picciani PHS, Dalmaschio CJ, Davis F, Shimizu FM. Magnetic nanoparticles in biomedical applications: a review. Appl Surf Sci Adv. 2021;6:100163. https:\/\/doi.org\/10.1016\/j.apsadv.2021.100163.","journal-title":"Appl Surf Sci Adv"},{"key":"1701_CR52","doi-asserted-by":"publisher","first-page":"171574","DOI":"10.1016\/j.jmmm.2023.171574","volume":"589","author":"F Fern\u00e1ndez-\u00c1lvarez","year":"2024","unstructured":"Fern\u00e1ndez-\u00c1lvarez F, Garc\u00eda-Garc\u00eda G, Iglesias GR, Arias JL. A maghemite\/PLGA (core\/shell) nanostructure that may facilitate chemotherapy and antitumor hyperthermia. J Magn Magn Mater. 2024;589:171574. https:\/\/doi.org\/10.1016\/j.jmmm.2023.171574.","journal-title":"J Magn Magn Mater"},{"key":"1701_CR53","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/13543776.2015.1028358","volume":"25","author":"MM El-Hammadi","year":"2015","unstructured":"El-Hammadi MM, Arias JL. Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008 - present). Expert Opin Ther Pat. 2015;25:691\u2013709. https:\/\/doi.org\/10.1517\/13543776.2015.1028358.","journal-title":"Expert Opin Ther Pat"},{"key":"1701_CR54","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1039\/C2JM15339D","volume":"22","author":"JL Arias","year":"2012","unstructured":"Arias JL, Reddy LH, Couvreur P. Fe3O4\/chitosan nanocomposite for magnetic drug targeting to cancer. J Mater Chem. 2012;22:7622\u201332. https:\/\/doi.org\/10.1039\/C2JM15339D.","journal-title":"J Mater Chem"},{"key":"1701_CR55","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.nano.2023.102695","volume":"52","author":"G Garc\u00eda-Garc\u00eda","year":"2023","unstructured":"Garc\u00eda-Garc\u00eda G, Caro C, Fern\u00e1ndez-\u00c1lvarez F, Garc\u00eda-Mart\u00edn ML, Arias JL. Multi-stimuli-responsive chitosan-functionalized magnetite\/poly(epsilon-caprolactone) nanoparticles as theranostic platforms for combined tumor magnetic resonance imaging and chemotherapy. Nanomedicine. 2023;52:102695. https:\/\/doi.org\/10.1016\/j.nano.2023.102695.","journal-title":"Nanomedicine"},{"key":"1701_CR56","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ijbiomac.2021.06.184","volume":"186","author":"S Kazemi","year":"2021","unstructured":"Kazemi S, Pourmadadi M, Yazdian F, Ghadami A. The synthesis and characterization of targeted delivery curcumin using chitosan-magnetite-reduced graphene oxide as nano-carrier. Int J Biol Macromol. 2021;186:554\u201362. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.06.184.","journal-title":"Int J Biol Macromol"},{"key":"1701_CR57","doi-asserted-by":"publisher","first-page":"100567","DOI":"10.1016\/j.rechem.2022.100567","volume":"4","author":"MK Al-Hussainawy","year":"2022","unstructured":"Al-Hussainawy MK, Sahb Mehdi Z, Jasim KK, Alshamsi HA, Saud HR, Kyhoiesh HAK. A single rapid route synthesis of magnetite\/chitosan nanocomposite: competitive study. Results Chem. 2022;4:100567. https:\/\/doi.org\/10.1016\/j.rechem.2022.100567.","journal-title":"Results Chem"},{"key":"1701_CR58","doi-asserted-by":"publisher","first-page":"36295","DOI":"10.1016\/j.ceramint.2024.07.013","volume":"50","author":"G Garc\u00eda-Garc\u00eda","year":"2024","unstructured":"Garc\u00eda-Garc\u00eda G, L\u00e1zaro M, Cenalmor A, Garc\u00eda-\u00c1lvarez I, Iglesias GR, Arias JL. Cluster\/shell citrate-Fe3O4\/chitosan nanoparticles for enhancing heating efficiency in combined magnetic and photothermal therapy. Ceram Int. 2024;50:36295\u2013305. https:\/\/doi.org\/10.1016\/j.ceramint.2024.07.013.","journal-title":"Ceram Int"},{"key":"1701_CR59","doi-asserted-by":"publisher","first-page":"171500","DOI":"10.1016\/j.jmmm.2023.171500","volume":"588","author":"G Garc\u00eda-Garc\u00eda","year":"2023","unstructured":"Garc\u00eda-Garc\u00eda G, L\u00e1zaro-Callej\u00f3n M, Fern\u00e1ndez-\u00c1lvarez F, Iglesias GR, Arias JL. (Magnetite\/poly(\u03b5-caprolactone))\/chitosan (core\/shell)\/shell nanocomposites with potential applications in hyperthermia cancer therapy. J Magn Magn Mater. 2023;588:171500. https:\/\/doi.org\/10.1016\/j.jmmm.2023.171500.","journal-title":"J Magn Magn Mater"},{"key":"1701_CR60","doi-asserted-by":"publisher","first-page":"111824","DOI":"10.1016\/j.colsurfb.2021.111824","volume":"204","author":"M Moskvin","year":"2021","unstructured":"Moskvin M, Hunto\u0161ov\u00e1 V, Herynek V, Matou\u0161 P, Michalcov\u00e1 A, Lobaz V, Zaso\u0144ska B, \u0160louf M, Seliga R, Hor\u00e1k D. In vitro cellular activity of maghemite\/cerium oxide magnetic nanoparticles with antioxidant properties. Colloids Surf B Biointerfaces. 2021;204:111824. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111824.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1701_CR61","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.colsurfb.2015.10.014","volume":"136","author":"K Fang","year":"2015","unstructured":"Fang K, Song L, Gu Z, Yang F, Zhang Y, Gu N. Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy. Colloids Surf B Biointerfaces. 2015;136:712\u201320. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.10.014.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1701_CR62","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3390\/polym12122790","volume":"12","author":"G Garc\u00eda-Garc\u00eda","year":"2020","unstructured":"Garc\u00eda-Garc\u00eda G, Fern\u00e1ndez-\u00c1lvarez F, Cabeza L, Delgado \u00c1V, Melguizo C, Prados JC, Arias JL. Gemcitabine-loaded magnetically responsive poly(epsilon-caprolactone) nanoparticles against breast cancer. Polym (Basel). 2020;12:2790. https:\/\/doi.org\/10.3390\/polym12122790.","journal-title":"Polym (Basel)"},{"key":"1701_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpharm.2016.03.005","volume":"504","author":"M Mu\u00f1oz de Escalona","year":"2016","unstructured":"Mu\u00f1oz de Escalona M, S\u00e1ez-Fern\u00e1ndez E, Prados JC, Melguizo C, Arias JL. Magnetic solid lipid nanoparticles in hyperthermia against colon cancer. Int J Pharm. 2016;504:11\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.005.","journal-title":"Int J Pharm"},{"key":"1701_CR64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.colsurfa.2011.03.051","volume":"384","author":"JL Arias","year":"2011","unstructured":"Arias JL, L\u00f3pez-Viota M, S\u00e1ez-Fern\u00e1ndez E, Ruiz MA, Delgado \u00c1V. Engineering of an antitumor (core\/shell) magnetic nanoformulation based on the chemotherapy agent ftorafur. Colloids Surf Physicochem Eng Aspects. 2011;384:157\u201363. https:\/\/doi.org\/10.1016\/j.colsurfa.2011.03.051.","journal-title":"Colloids Surf Physicochem Eng Aspects"},{"key":"1701_CR65","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1007\/s11051-011-0378-z","volume":"13","author":"DP Santos","year":"2011","unstructured":"Santos DP, Ruiz MA, Gallardo V, Zanoni MVB, Arias JL. Multifunctional antitumor magnetite\/chitosan-l-glutamic acid (core\/shell) nanocomposites. J Nanopart Res. 2011;13:4311\u201323. https:\/\/doi.org\/10.1007\/s11051-011-0378-z.","journal-title":"J Nanopart Res"},{"key":"1701_CR66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/138920010791110827","volume":"11","author":"J Wang","year":"2010","unstructured":"Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab. 2010;11:129\u201341. https:\/\/doi.org\/10.2174\/138920010791110827.","journal-title":"Curr Drug Metab"},{"key":"1701_CR67","doi-asserted-by":"publisher","first-page":"104982","DOI":"10.1016\/j.jddst.2023.104982","volume":"89","author":"M L\u00f3pez-Viota","year":"2023","unstructured":"L\u00f3pez-Viota M, Mart\u00edn-Pozo L, Parera B, V\u00edlchez JL, Viota JL, Alhareth K, El-Hammadi ME. Varying coat properties of chitosan-surface modified polya (lactic-co-glycolic acid) nanoparticles for controlled delivery of 5-fluorouracil. J Drug Deliv Sci Technol. 2023;89:104982. https:\/\/doi.org\/10.1016\/j.jddst.2023.104982.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1701_CR68","doi-asserted-by":"publisher","first-page":"104459","DOI":"10.1016\/j.reactfunctpolym.2019.104459","volume":"147","author":"LA Frank","year":"2020","unstructured":"Frank LA, Onzi GR, Morawski AS, Pohlmann AR, Guterres SS, Contri RV. Chitosan as a coating material for nanoparticles intended for biomedical applications. React Funct Polym. 2020;147:104459. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2019.104459.","journal-title":"React Funct Polym"},{"key":"1701_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12668-020-00797-z","volume":"11","author":"M Raval","year":"2021","unstructured":"Raval M, Patel P, Airao V, Sheth N. Novel silibinin loaded chitosan-coated PLGA\/PCL nanoparticles based inhalation formulations with improved cytotoxicity and bioavailability for lung cancer. BioNanoSci. 2021;11:67\u201383. https:\/\/doi.org\/10.1007\/s12668-020-00797-z.","journal-title":"BioNanoSci"},{"key":"1701_CR70","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","volume":"31","author":"C He","year":"2010","unstructured":"He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657\u201366. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.01.065.","journal-title":"Biomaterials"},{"key":"1701_CR71","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1166\/jbn.2016.2263","volume":"12","author":"SH Voon","year":"2016","unstructured":"Voon SH, Tiew SX, Kue CS, Lee HB, Kiew LV, Misran M, Kamkaew A, Burgess K, Chung LY. Chitosan-coated poly(lactic-co-glycolic acid)-diiodinated boron-dipyrromethene nanoparticles improve tumor selectivity and stealth properties in photodynamic cancer therapy. J Biomed Nanotechnol. 2016;12:1431\u201352. https:\/\/doi.org\/10.1166\/jbn.2016.2263.","journal-title":"J Biomed Nanotechnol"},{"key":"1701_CR72","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.3390\/molecules25204758","volume":"25","author":"C Moraru","year":"2020","unstructured":"Moraru C, Mincea M, Menghiu G, Ostafe V. Understanding the factors influencing Chitosan-based nanoparticles-protein corona interaction and drug delivery applications. Molecules. 2020;25:4758. https:\/\/doi.org\/10.3390\/molecules25204758.","journal-title":"Molecules"},{"key":"1701_CR73","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1021\/acsestengg.3c00109","volume":"3","author":"J Amber","year":"2023","unstructured":"Amber J, Pete AJ, Lee JG, Michael G, Benton MG, Bharti B. Chitosan-Coated Lignin nanoparticles enhance adsorption and proliferation of Alcanivorax borkumensis at the hexadecane\u2013water interface. ACS ES&T Eng. 2023;3:1339\u201349. https:\/\/doi.org\/10.1021\/acsestengg.3c00109.","journal-title":"ACS ES&T Eng"},{"key":"1701_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/pls2.10069","volume":"3","author":"V Kulikouskaya","year":"2022","unstructured":"Kulikouskaya V, Hileuskaya V, Kraskouski K, Kozerozhets A, Stepanova I, Kuzminski E, You I, Agabekov L. Chitosan-capped silver nanoparticles: a comprehensive study of polymer molecular weight effect on the reaction kinetic, physicochemical properties, and synergetic antibacterial potential. SPE Polym. 2022;3:77. https:\/\/doi.org\/10.1002\/pls2.10069.","journal-title":"SPE Polym"},{"key":"1701_CR75","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.msec.2014.12.036","volume":"48","author":"Y Ding","year":"2015","unstructured":"Ding Y, Shen SZ, Sun H, Sun K, Liu F, Qi Y, Yan J. Design and construction of polymerized-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery. Mater Sci Eng C Mater Biol. 2015;48:487\u201398. https:\/\/doi.org\/10.1016\/j.msec.2014.12.036.","journal-title":"Mater Sci Eng C Mater Biol"},{"key":"1701_CR76","doi-asserted-by":"publisher","unstructured":"Matusiak J, Grz\u0105dka E, Bastrzyk A, Stability. Adsorption and Electrokinetic Properties of the Chitosan\/Silica system. Colloids Surf Physicochem Eng Asp. 2018;554:245\u201352. https:\/\/doi.org\/10.1016\/j.colsurfa.2018.06.05.","DOI":"10.1016\/j.colsurfa.2018.06.05"},{"key":"1701_CR77","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.carbpol.2018.12.046","volume":"207","author":"A Franconetti","year":"2019","unstructured":"Franconetti A, Carnerero JM, Prado-Gotor R, Cabrera-Escribano F, Jaime C. Chitosan as a Capping Agent: insights on the stabilization of gold nanoparticles. Carbohydr Polym. 2019;207:806\u201314. https:\/\/doi.org\/10.1016\/j.carbpol.2018.12.046.","journal-title":"Carbohydr Polym"},{"key":"1701_CR78","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.foodhyd.2019.03.042","volume":"94","author":"D Pauluk","year":"2019","unstructured":"Pauluk D, Padilha AK, Khalil NM, Mainardes RM. Chitosan-coated zein nanoparticles for oral delivery of resveratrol: formation, characterization, stability, mucoadhesive properties and antioxidant activity. Food Hydrocolloids. 2019;94:411\u20137. https:\/\/doi.org\/10.1016\/j.foodhyd.2019.03.042.","journal-title":"Food Hydrocolloids"},{"issue":"202","key":"1701_CR79","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.carbpol.2018.08.142","volume":"15","author":"RGDJ V\u00e1squez Marcano","year":"2018","unstructured":"V\u00e1squez Marcano RGDJ, Tominaga TT, Khalil NM, Pedroso LS, Mainardes RM. Chitosan functionalized poly (\u03b5-caprolactone) nanoparticles for amphotericin B delivery. Carbohydr Polym. 2018;15(202):345\u201354. https:\/\/doi.org\/10.1016\/j.carbpol.2018.08.142.","journal-title":"Carbohydr Polym"},{"key":"1701_CR80","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1166\/jbn.2009.1073","volume":"5","author":"P Wu","year":"2009","unstructured":"Wu P, He X, Wang K, Tan W, He C, Zheng M. A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. J Biomed Nanotechnol. 2009;5:557\u201364. https:\/\/doi.org\/10.1166\/jbn.2009.1073.","journal-title":"J Biomed Nanotechnol"},{"key":"1701_CR81","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1208\/s12249-015-0445-3","volume":"18","author":"HR Naghibi Beidokhti","year":"2017","unstructured":"Naghibi Beidokhti HR, Ghaffarzadegan R, Mirzakhanlouei S, Ghazizadeh L, Dorkoosh FA. Preparation, characterization, and optimization of Folic Acid-Chitosan-Methotrexate Core-Shell nanoparticles by Box-Behnken Design for Tumor-targeted drug delivery. AAPS PharmSciTech. 2017;18:115\u201329. https:\/\/doi.org\/10.1208\/s12249-015-0445-3.","journal-title":"AAPS PharmSciTech"},{"key":"1701_CR82","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.carbpol.2014.05.012","volume":"111","author":"C Gao","year":"2014","unstructured":"Gao C, Liu T, Dang Y, Yu Z, Wang W, Guo J, Zhang X, He G, Zheng H, Yin Y, Kong X. pH\/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate. Carbohydr Polym. 2014;111:964\u201370. https:\/\/doi.org\/10.1016\/j.carbpol.2014.05.012.","journal-title":"Carbohydr Polym"},{"key":"1701_CR83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12967-022-03267-0","volume":"20","author":"JS Park","year":"2022","unstructured":"Park JS, Lee D, Yang S, Jeong HY, Na HS, Cho KH, Choi J, Koo H, Cho ML, Park SH. Methotrexate-loaded nanoparticles ameliorate experimental model of autoimmune arthritis by regulating the balance of interleukin-17-producing T cells and regulatory T cells. J Transl Med. 2022;20:85. https:\/\/doi.org\/10.1186\/s12967-022-03267-0.","journal-title":"J Transl Med"},{"key":"1701_CR84","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ijbiomac.2016.11.098","volume":"95","author":"MM Badran","year":"2017","unstructured":"Badran MM, Mady MM, Ghannam MM, Shakeel F. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer. Int J Biol Macromol. 2017;95:643\u201349. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.11.098.","journal-title":"Int J Biol Macromol"},{"key":"1701_CR85","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.3390\/molecules25143159","volume":"25","author":"N Malhotra","year":"2020","unstructured":"Malhotra N, Lee JS, Liman RAD, Ruallo JMS, Villaflores OB, Ger TR, Hsiao CD. Potential toxicity of iron oxide magnetic nanoparticles: a review. Molecules. 2020;25:3159. https:\/\/doi.org\/10.3390\/molecules25143159.","journal-title":"Molecules"},{"key":"1701_CR86","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12951-015-0146-9","volume":"13","author":"MS Boyles","year":"2015","unstructured":"Boyles MS, Kristl T, Andosch A, Zimmermann M, Tran N, Casals E, Himly M, Puntes V, Huber CG, L\u00fctz-Meindl U, Duschl A. Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum components. J Nanobiotechnol. 2015;13:84. https:\/\/doi.org\/10.1186\/s12951-015-0146-9.","journal-title":"J Nanobiotechnol"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01701-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01701-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01701-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T02:08:33Z","timestamp":1743818913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01701-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01701-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4328624\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"19 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors read and approved the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}